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BRIEF DEFINITIVE REPORT
            The lung is highly susceptible to injury from sys-
temic (e.g., sepsis) or inhalational (e.g., acid aspira-
tion) exposures, and acute lung injury, manifesting 
clinically as adult respiratory distress syndrome 
(ARDS), exacts a huge human toll (  1  ). ARDS is 
characterized by apoptosis of pulmonary epithe-
lial and endothelial cells as well as of infi  ltrating 
neutrophils recruited during the infl  ammatory 
response to injury (  2  ). The surface binding/inges-
tion of ACs during macrophage eff  erocytosis 
has been shown to trigger release of antiinfl  am-
matory molecules, including TGF-    , IL-10, ni-
tric oxide, and PGE  2   (  3, 4  ), while inhibiting their 
secretion of proinfl  ammatory mediators such as 
TNF-    , IL-1, KC, IL-8, and leukotriene C  4   ( 3, 5 ). 
An antiinfl  ammatory program may be critical to 
restoration of homeostasis and prevention of fi  -
brosis after acute lung injury, as exemplifi  ed by 
the demonstration that intratracheal instillation of 
ACs enhanced the resolution of acute pulmonary 
infl  ammation induced by lipopolysaccharide (  6  ). 
However, it might also impair the lung  ’  s capac-
ity to defend itself against infection. Patients being 
treated in intensive care units for ARDS frequently 
develop bacterial pneumonia (  7  ), but the role of 
eff  erocytosis in its pathogenesis is diffi   cult to dis-
tinguish from that of other existing risk factors, 
including the altered lung architecture by itself, 
mechanical ventilation, nutritional defi  ciencies, 
and potentially immunosuppressive medications. 
This study was designed to specifi  cally character-
ize the impact of eff  erocytosis on antibacterial de-
fense of the lung and on its resident phagocyte, the 
alveolar macrophage (AM). 
    RESULTS AND DISCUSSION   
  Using a variety of recognition receptors for op-
sonins or pathogen-associated molecular patterns, 
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  The ingestion of apoptotic cells (ACs; termed   “  efferocytosis  ”  ) by phagocytes has been 
shown to trigger the release of molecules such as transforming growth factor     , interleu-
kin-10 (IL-10), nitric oxide, and prostaglandin E  2   (PGE  2  ). Although the antiinfl  ammatory 
actions of these mediators may contribute to the restoration of homeostasis after tissue 
injury, their potential impact on antibacterial defense is unknown. The lung is highly sus-
ceptible to diverse forms of injury, and secondary bacterial infections after injury are of 
enormous clinical importance. We show that ACs suppress in vitro phagocytosis and bacte-
rial killing by alveolar macrophages and that this is mediated by a cyclooxygenase  –  PGE  2    –  E 
prostanoid receptor 2 (EP2)  –  adenylyl cyclase  –  cyclic AMP pathway. Moreover, intrapulmo-
nary administration of ACs demonstrated that PGE  2   generated during efferocytosis and 
acting via EP2 accounts for subsequent impairment of lung recruitment of polymorpho-
nuclear leukocytes and clearance of   Streptococcus pneumoniae  , as well as enhanced gen-
eration of IL-10 in vivo. These results suggest that in addition to their benefi  cial 
homeostatic infl  uence, antiinfl  ammatory programs activated by efferocytosis in the lung 
have the undesirable potential to dampen innate antimicrobial responses. They also identify 
an opportunity to reduce the incidence and severity of pneumonia in the setting of lung 
injury by pharmacologically targeting synthesis of PGE  2   or ligation of EP2. 
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mediated ingestion of both targets was also time dependent 
over a 15  –  90-min pretreatment interval, and a 16-h pretreat-
ment resulted in near complete suppression (  Fig. 1 C  ). Simi-
lar inhibitory eff  ects were obtained when rat thymocytes, rat 
PMNs, or RLE-6TN rat lung epithelial cells were used as the 
source of ACs (unpublished data). Preincubation with either 
viable or necrotic cells had no eff  ect on subsequent FcR-me-
diated phagocytosis (  Fig. 1 D  ). After their ingestion, macro-
phages must kill bacteria. Preincubation with ACs (3:1) for 
90 min signifi  cantly enhanced the intracellular survival of 
phagocytosed bacteria, refl  ecting an impairment of AM mi-
crobicidal activity against IgG-opsonized   Klebsiella pneumoniae   
(  Fig. 1 E  ). Together, these results demonstrate that preexpo-
sure to ACs markedly impairs the ability of AMs to carry out 
two crucial functions involved in immune defense against 
bacterial pneumonia: microbial phagocytosis and killing. 
  We next assessed whether the inhibition of FcR-medi-
ated phagocytosis by eff  erocytosis in AMs was dependent on 
soluble mediators. Pretreatment of naive AMs with cell-free 
supernatant harvested from parallel AM cultures incubated 
for 90 min with ACs (3:1) inhibited subsequent FcR-medi-
ated phagocytosis to the same degree as did direct addition of 
AMs ingest and kill pathogens, thereby serving a critical func-
tion in immune defense of the delicate gas-exchanging re-
gion of the lung. One such receptor that plays an important 
role in antimicrobial responses (  8  ) and that has been exten-
sively investigated (  9  ) is the Fc     receptor (FcR) for IgG anti-
bodies. To determine if efferocytosis suppresses in vitro 
FcR-mediated phagocytosis, rat AMs were preincubated 
with diff  erent ratios of ACs and then challenged with IgG-
opsonized erythrocytes (RBCs) or   Escherichia coli   for 90 min. 
As a source of ACs, we used Jurkat T cells treated with camp-
tothecin using a protocol resulting in 25.6% of cells in early 
apoptosis with only 3.1% contamination by late apoptotic or 
necrotic cells (  Fig. 1 A  ).   Because Fadok et al. (  3  ) previously 
demonstrated that PGE  2   production by human macrophages 
occurred after 90 min of incubation with ACs, we initially 
used this pretreatment interval. Microscopic visualization 
(unpublished data) indicated that AMs bound and ingested 
ACs, as previously reported (  10  ). Preincubation of AMs for 
90 min with various ratios of ACs dose-dependently inhib-
ited subsequent FcR-mediated pha  gocytosis of both RBCs 
and   E. coli   (  Fig. 1 B  ), with   ≥  50% inhibition being observed at 
AC/AM ratios of 3:1. The inhibition by ACs (3:1) of FcR-
    Figure 1.         Efferocytosis inhibits FcR-mediated phagocytosis and bacterial killing by AMs.   (A) Jurkat T cells were incubated with 8   μ  g/ml campto-
thecin for 5 h and apoptotic cells were detected by AnnexinV-FITC/PI and analyzed by fl  ow cytometry. Early ACs represent 25.69% of cells. (B) Phagocyto-
sis of IgG RBCs or IgG   E. coli   was determined after a 90-min pretreatment with ACs at the indicated AC/AM ratios. (C) Phagocytosis of IgG RBCs was 
determined after pretreatment for the indicated times with ACs added at a ratio of 3:1. (D) Phagocytosis of IgG RBCs was determined after a 90-min 
pretreatment with viable (VC) or necrotic (NC) Jurkat cells added at a ratio of 3:1. (E) AMs were preincubated with or without ACs (3:1) for 90 min and 
then infected with   K. pneumoniae   (50:1). Microbicidal activity was determined and expressed as the percentage survival of ingested bacteria. Results rep-
resent the mean   ±   SEM from three independent experiments, each performed in quintuplicate (B  –  D) or the mean   ±   SEM of quintuplicate values from a 
single experiment representative of three independent experiments (A and E). *, P   <   0.05 versus control.     JEM VOL. 206, January 19, 2009  63
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inhibited by aspirin (  Fig. 2 B  ). These results suggest that 
endogenous PGE  2  , produced after binding/ingestion of ACs, 
is a candidate COX-derived mediator of the immunosup-
pression of FcR-mediated phagocytosis in AMs. Freire-
de-Lima et al. (  15  ) reported that peritoneal or RAW 264.7 
macrophages incubated with apoptotic Jurkat cells for 18 h 
generated increased amounts of TGF-    , and PGE  2   produc-
tion was inhibited when TGF-     responses were blocked 
using a dominant negative receptor. In our experimental sys-
tem, however, we observed no increase over control in 
TGF-     levels measured in culture supernatants derived from 
incubations of ACs/AMs after either 90 min or 16 h (unpub-
lished data). Ren et al. (  16  ) recently demonstrated in den-
dritic cells that nitric oxide, but not IL-10, TGF-    , or PGE  2  , 
mediates the immunosuppressive eff   ects induced by ACs. 
These fi  ndings suggest that the soluble mediators involved in 
the suppression of various immune responses after eff  erocy-
tosis may depend largely on the type and activation state of 
the phagocytes. 
ACs themselves (  Fig. 2 A  ), implicating a soluble factor.   Both 
eff  erocytosing macrophages (  3, 4  ) and ACs themselves (  11  ) 
can generate and release TGF-    , and it has been reported 
that TGF-     can induce PGE  2   production (  12, 13  ). However, 
the inability of a neutralizing antibody against TGF-     to 
reverse phagocytosis suppression induced by AC pretreat-
ment for either 90 min (  Fig. 2 A  ) or 16 h (not depicted) sug-
gests that eff  erocytosis-induced inhibition was independent 
of TGF-    . 
  Inasmuch as the interaction with ACs leads human mac-
rophages to also secrete PGE  2   (  3  ), and we have reported that 
endogenously produced PGE  2   inhibits FcR-mediated phago-
cytosis by AMs (  14  ), we evaluated the role of endogenous 
prostanoids in the suppression of FcR-mediated phagocyto-
sis. Pretreatment with the cyclooxygenase (COX) inhibitors 
indomethacin and aspirin completely abrogated the inhibi-
tion of FcR-mediated phagocytosis by ACs, and such inhibi-
tion was reproduced by addition of exogenous PGE  2   (  Fig. 2 A  ). 
Indeed, AMs secreted PGE  2   in response to ACs and this was 
    Figure 2.         PGE  2   mediates the suppressive effects of efferocytosis on AM antimicrobial functions via EP2.   (A) AMs were pretreated with culture 
supernatant derived from parallel incubations of ACs/AMs (3:1), with 5   μ  M PGE  2  , or with 3:1 ACs in the absence or presence of 6   μ  g/ml of anti  –  TGF-    
blocking antibody or 5   μ  M of the COX inhibitors indomethacin (Indo) and 200   μ  M of aspirin (Asp). They were subsequently challenged with IgG RBCs and 
phagocytosis was determined. (B) AMs were incubated with medium alone or with ACs in the presence or absence of aspirin. PGE  2   in supernatant was 
quantitated by immunoassay after 30 min. (C) AM phagocytosis of IgG RBCs was determined after a 90-min pretreatment with medium alone or with 
ACs (3:1) in the absence or presence of 100   μ  M of the EP2 antagonist AH-6809. (D) AMs from EP2     /     or WT control mice were preincubated with or with-
out apoptotic thymocytes (5:1) for 90 min before challenge with IgG RBCs and phagocytosis was determined. Results represent the mean   ±   SEM from 
three independent experiments, each performed in quintuplicate (A  –  C) or the mean   ±   SEM of quintuplicate values from one experiment representative of 
three independent experiments (D). *, P   <   0.05 versus control; #, P   <   0.05 versus AC.     64 EFFEROCYTOSIS IMPAIRS LUNG INNATE IMMUNITY   | Medeiros et al. 
  We have reported that the suppressive eff  ects of PGE  2   on 
AM antimicrobial functions are primarily mediated by its 
binding to the EP2 receptor, a G    s-coupled receptor that ac-
tivates adenylyl cyclase activity with resulting cAMP forma-
tion (  14, 17, 18  ). To assess the specifi  c contribution of PGE  2  , 
among other prostanoids, to the eff  erocytosis-induced inhibi-
tion of FcR-mediated phagocytosis and to specifi  cally dissect 
the participation of EP2 in this process, AMs were pretreated 
with ACs in the presence or absence of the EP2 antagonist 
AH-6809 and then challenged with IgG RBCs. Inhibition of 
FcR phagocytosis by ACs was completely abrogated by the 
EP2 antagonist (  Fig. 2 C  ). Moreover, AC pretreatment of 
AMs harvested from mice genetically defi  cient in the EP2 
receptor was unable to signifi  cantly inhibit FcR-mediated 
phagocytosis as it was in cells from WT mice (  Fig. 2 D  ). 
The suppressive eff  ect of ACs on AM phagocytosis was also 
abrogated when these cells were pretreated with the adenylyl 
cyclase inhibitor SQ 22536 (  Fig. 3 A  ).   In addition, inhibition 
of phagocytosis by ACs directly correlated with increased in-
tracellular levels of cAMP, which was also abrogated by aspi-
rin and SQ 22536 (  Fig. 3 B  ). Bactericidal capacity in the 
context of eff  erocytosis was likewise markedly augmented by 
coincubation with a COX inhibitor, an EP2 antagonist, or an 
adenylyl cyclase inhibitor (  Fig. 3 C  ). These results demon-
strate that PGE  2  , acting via an EP2  –  adenylyl cyclase  –  cAMP 
pathway, mediates the suppressive eff  ects of eff  erocytosis on 
FcR-mediated antimicrobial functions by AMs. 
  To confi  rm the biological signifi  cance of these in vitro 
results, we modeled a secondary lung infection after initial 
pulmonary exposure to ACs such as what would be seen in 
acute lung injury. For these experiments, ACs were gener-
ated by dexamethasone treatment of murine thymocytes for 
6 h, which yielded 40.3% early apoptotic and 4.93% late 
apoptotic plus necrotic cells (  Fig. 4 A  ).   Initially, diff  erent num-
bers of ACs were coadministered intratracheally in C57BL/6 
WT mice along with a standard inoculum of the important 
respiratory pathogen   Streptococcus pneumoniae  , and 48 h after 
challenge the bacterial burdens in lung homogenates were 
evaluated. As shown in   Fig. 4 B  , there was no diff  erence in 
pulmonary bacterial clearance of mice that were infected and 
simultaneously exposed to ACs using this protocol compared 
with those infected alone. Because our in vitro results indi-
cated that the eff  erocytosis-induced inhibition of FcR-medi-
ated phagocytosis was time dependent and reached a level of 
89% when phagocytic target challenge was performed after 
an interval of 16 h (  Fig. 1 C  ), we devised a second model in 
which   S. pneumoniae   was administered intratracheally 16 h 
after various numbers of apoptotic thymocytes were instilled 
intranasally. As     55% of the total numbers of cells obtained 
after treatment of thymocytes with dexamethasone remain 
viable, viable cells were also administrated intranasally as an 
experimental control. Results showed that pretreatment with 
ACs, but not viable cells, using this protocol dose-depend-
ently impaired pulmonary bacterial clearance (  Fig. 4 C  ) and 
also led to the dissemination of   S. pneumoniae   into the blood-
stream (  Fig. 4 D  ) 48 h after infection. Finally, to test the role 
    Figure 3.         Adenylyl cyclase generation of cAMP mediates the sup-
pressive effects of efferocytosis on AM antimicrobial functions.  
(A) Phagocytosis of IgG RBCs or IgG   E. coli   was determined after 90-min 
pretreatment with ACs (3:1) in the absence or presence of 10   μ  M of the 
adenylyl cyclase inhibitor SQ 22536. (B) AMs were pretreated or not with 
200   μ  M of aspirin or 10   μ  M of the adenylyl cyclase inhibitor SQ 22536 
before addition of ACs or vehicle for 30 min. Intracellular cAMP concen-
trations were determined by enzyme immunoassay. (C) AMs were preincu-
bated with 100   μ  M of the EP2 antagonist AH-6809, 200   μ  M of aspirin, 
10   μ  M of the adenylyl cyclase inhibitor SQ 22536, or vehicle before the 
addition of   K. pneumoniae   (50:1). Microbicidal activity was assessed and 
intracellular survival of bacteria is expressed as a percentage of the con-
trol, to which no AC were added. Results represent the mean   ±   SEM 
from three independent experiments, each performed in quintuplicate. 
*, P   <   0.05 versus control; #, P   <   0.05 versus AC.     JEM VOL. 206, January 19, 2009  65
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lower than in AC-pretreated WT mice (  Fig. 4 E  ). In addi-
tion, EP2      /      mice exhibited no bacteremia (  Fig. 4 F  ). Be-
cause these mice lack preexisting antibodies against   S. 
pneumoniae  , bacterial recognition and clearance by phagocytes 
in the in vivo model is likely independent of FcR, indicat-
ing that the PGE  2  /EP2/cAMP axis also suppresses innate 
of the EP2 receptor in this impairment of in vivo pulmonary 
defense against   S. pneumoniae   by AC pretreatment, we com-
pared the lung and the bloodstream bacterial burdens in WT 
versus EP2      /      mice. In contrast with WT mice, the pulmo-
nary bacterial burden in AC-pretreated EP2      /      mice was no 
greater than in non  –  AC-pretreated controls but was 2.5 logs 
    Figure 4.         Intrapulmonary administration of ACs impairs host defense in a mouse model of pneumococcal pneumonia.   (A) Thymocytes were 
incubated with 1   μ  M dexamethasone for 6 h and ACs were detected by AnnexinV-FITC/PI and analyzed by fl  ow cytometry. Early ACs comprise 40.3% of 
total cells. (B) 10  6   CFU of   S. pneumoniae   and varying numbers of apoptotic thymocytes were coadministered intratracheally in WT mice. Lung homoge-
nates were assessed for bacterial CFUs 48 h later. (C) Indicated numbers of apoptotic or viable thymocytes were instilled intranasally in WT mice and, 
16 h later, 10  6   CFU   S. pneumoniae   were administered intratracheally. Lung homogenates were assessed for bacterial CFUs 48 h after   S. pneumoniae   chal-
lenge. (D) Bacterial CFUs were determined in blood obtained 48 h after   S. pneumoniae   challenge from the same WT mice studied in C. (E) WT and EP2     /    
mice were subjected to intranasal administration of apoptotic thymocytes 16 h before intratracheal challenge with   S. pneumoniae   as described in C. Lung 
homogenate CFUs 48 h after bacterial challenge are presented. (F) Bacterial CFUs were determined in blood obtained 48 h after   S. pneumoniae   challenge 
from the same EP2     /     mice studied in E. Results represent the mean   ±   SEM of one experiment representative of two. The number of animals analyzed in 
each group is indicated above each bar. ND, none detected. *, P   <   0.05 versus control; #, P   <   0.05 versus AC.     66 EFFEROCYTOSIS IMPAIRS LUNG INNATE IMMUNITY   | Medeiros et al. 
rocytosis infl  uenced PMN infl  ux to the lungs of infected 
mice. Intrapulmonary instillation of apoptotic thymocytes had 
no impact on total and diff  erential cell counts in bronchoal-
veolar lavage fl  uid (BALF) obtained 16 h later from nonin-
fected WT mice (unpublished data). However, pretreatment 
with ACs 16 h before infection with   S. pneumoniae   dose-de-
pendently reduced the numbers of total cells (not depicted) 
and PMNs (  Fig. 5 D  ), but not mononuclear cells (not de-
picted), in BALF harvested 48 h after infection. EP2      /      mice 
infected with   S. pneumoniae   exhibited signifi  cantly  lower 
numbers of total BALF cells and PMNs than WT animals, an 
eff  ect likely related to reduced alveolar capillary permeability 
(unpublished data). However, in contrast to their WT coun-
terparts, AC pretreatment failed to attenuate PMN recruit-
ment in EP2      /      mice (  Fig. 5 D  ). These results suggest that 
PGE  2  /EP2 signaling also mediates the impairment in PMN 
recruitment to the infected lung, which likely contributes to 
defective bacterial clearance. 
  In a mouse model of Chagas disease, administration of 
ACs was found to enhance   Trypanosoma cruzi   parasitemia, an 
eff  ect blocked by COX inhibitors; however, this study did 
not use the natural route of inoculation via the skin (  12  ). 
Ours is the fi  rst in vivo study to use a natural route of micro-
bial inoculation, the fi  rst to address antibacterial defenses, and 
immune responses when bacterial recognition proceeds via 
other relevant recognition receptors such as toll-like recep-
tors (  19  ), collectins (  20  ), or scavenger receptors (  21  ). 
  We next sought to address the impact of PGE  2  /EP2 sig-
naling on lung levels of antiinfl  ammatory mediators. TGF-     
has previously been implicated as an important antiinfl  amma-
tory mediator in the lung in vivo (  6  ). We verifi  ed that lung 
homogenate TGF-     and IL-10 levels were indeed dose-de-
pendently increased 16 h after the administration of thymo-
cytes in uninfected WT mice. In contrast, levels of NO  2          (the 
stable oxidized derivative of nitric oxide) were unchanged 
(unpublished data). As expected, PGE  2   levels in lung homoge-
nates of infected animals were increased after administration of 
ACs (  Fig. 5 A  ).     S. pneumoniae   infection in WT mice increased 
lung homogenate levels of TGF-     and NO  2          but not IL-10 
(unpublished data). In this experimental context, administra-
tion of ACs had no eff  ect on lung levels of either NO  2          or 
TGF-     (  Fig. 5 B  ) but signifi  cantly increased levels of IL-10 
(  Fig. 5 C  ). This increase in IL-10 generation after AC admin-
istration was not seen in EP2      /      animals (  Fig. 5 C  ). These 
studies show that PGE  2  /EP2 signaling drives the enhanced IL-10 
production associated with eff  erocytosis in vivo. 
  In view of the contribution of PMN recruitment to anti-
bacterial defense of the lung, we next assessed whether eff  e-
    Figure 5.         PGE  2  /EP2 signaling impairs PMN recruitment and promotes   in vivo   generation of IL-10 in a     mouse model of pneumococcal pneu-
moniae  . 10  6   apoptotic thymocytes were instilled intranasally in WT and EP2     /     mice and, 16 h later, 10  6   CFU   S. pneumoniae   were administered intratra-
cheally.  (A – C)  PGE 2   (A), total TGF-     (B), and IL-10 levels (C) were quantifi  ed in the supernatant of lung homogenates from animals studied in   Fig. 4 
(C and E)  . (D) PMNs in BALF from WT and EP2     /     mice were counted. Results represent the mean   ±   SEM of one experiment representative of two (A  –  C) or 
of one experiment (D). The number of animals analyzed in each group is indicated above each bar. *, P   <   0.05 versus control; #, P   <   0.05 versus AC.     JEM VOL. 206, January 19, 2009  67
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  Measurement of cAMP, PGE  2  , IL-10, TGF-    , and NO  2           levels.   
  Intracellular cAMP levels in AM lysates (  34, 35  ), and PGE  2   (  35  ), IL-10, and 
TGF-     levels in culture supernatants or lung homogenates were quantifi  ed 
by ELISA. NO  2          (the stable oxidized derivative of nitric oxide) was deter-
mined using the Greiss reaction (  36  ). 
  In vivo experiments.     WT and EP2      /      mice were subjected to intratracheal 
or intranasal administration of ACs or viable cells in PBS. Either simultaneously 
or 16 h thereafter, 10  6   CFU   S. pneumonia   were administered intratracheally. 
Lung homogenates and blood were assessed for bacterial CFUs 48 h after   S. 
pneumoniae   challenge (  S. pneumoniae   provided by P. Mancuso, University of 
Michigan, Ann Arbor, MI). In another set of experiments, BAL was performed 
with 3 ml HBSS 16 h after instillation of ACs or 48 h after infection with   S. 
pneumoniae  . Cell counts and diff  erentials were determined by light microscopy. 
  Statistical analysis.     Data are presented as the mean   ±   SEM. Comparisons 
among groups were assessed with ANOVA followed by Bonferroni analysis. 
Diff  erences were considered signifi  cant if P-values were   <  0.05. 
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other category of disease (  22  ), the implications of these fi  nd-
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the most conspicuous example of such a scenario, chronic 
lung diseases such as cystic fi  brosis (  23  ) and emphysema (  24  ) 
also involve ongoing apoptosis and confer a high risk of in-
fection (  25, 26  ). The capacities of AMs to bind and ingest 
ACs (  10, 27  ), as well as to generate prostanoids including 
PGE  2   (  28  ), are known to be reduced relative to those of 
peritoneal macrophages. For this reason, it was not obvious 
that either eff  erocytosis itself or PGE  2   generated under such 
conditions would mediate suppression of antimicrobial de-
fense in AMs in vitro or in the lung in vivo. Nevertheless, 
the studies reported here demonstrate that eff  erocytosing 
AMs generate suffi   cient PGE  2   as well as suffi   cient EP2-me-
diated signaling responses to this lipid mediator to largely 
account for impairment of subsequent antibacterial re-
sponses in vitro and in vivo. As a variety of COX inhibitors 
are currently available, and as EP2 antagonists are under 
active development, our fi  ndings suggest that therapeutic 
targeting of this pathway has the potential to augment in-
nate immunity in the lung under conditions characterized 
by apoptosis. 
  MATERIALS AND METHODS 
  Reagents.     RPMI 1640 and penicillin/streptomycin/amphotericin B solu-
tion were purchased from Invitrogen. Camptothecin and dexamethasone 
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from R  &  D Systems. TGF-     and IL-10 ELISAs were obtained from BD. 
Compounds requiring reconstitution were dissolved in DMSO. 
  Animals.     EP2      /      mice on a C57BL/6 background (  29  ) (Ono Pharmaceuti-
cal), WT C57BL/6 mice (The Jackson Laboratory), and Wistar rats (Charles 
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versity of Michigan Committee for the Use and Care of Animals. 
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